Cochrane Database of Systematic Reviews Protocol - Intervention
Aminobisphosphonates versus other active treatment for Paget's disease of the bone in adults
Version published: 18 October 2004 Version history
This is not the most recent version
Related content
Related reviews and protocols
Luis Corral‐Gudino, Adrian JH Tan, Javier del Pino‐Montes, Stuart H Ralston | 1 December 2017
Leanne Ward, Andrea Tricco, Phuc‐Nhi Phuong, Ann Cranney, Nick Barrowman, Isabelle Gaboury, Frank Rauch, Peter Tugwell, David Moher | 17 October 2007
Tania M Winzenberg, Sandi Powell, Kelly A Shaw, Graeme Jones | 6 October 2010
Claire S Allen, James HS Yeung, Ben Vandermeer, Joanne Homik | 5 October 2016
George A Wells, Ann Cranney, Joan Peterson, Michel Boucher, Beverley Shea, Vivian Welch, Doug Coyle, Peter Tugwell | 23 January 2008
Siobhan O'Donnell, Ann Cranney, George A Wells, Jonathan Adachi, Jean-Yves Reginster | 18 October 2006
George A Wellsa, Shu-Ching Hsieha, Joan Peterson, Carine Zheng, Shannon E Kelly, Beverley Shea, Peter Tugwell | 9 April 2024
Vicente Ruiz Garcia, Amanda Burls, Juan B Cabello, Paloma Vela Casasempere, Sylvia Bort‐Marti, José A Bernal | 8 September 2017
Yunxia Liu, Jian Ping Liu, Yun Xia | 6 March 2014
Lucía Méndez-Sánchez, Patricia Clark, Tania M Winzenberg, Peter Tugwell, Paulina Correa-Burrows, Rebecca Costello | 27 January 2023
Cochrane Clinical Answers
How does zoledronate compare with pamidronate or risedronate in adults with Paget's disease of bone?
Christopher Bunt | 20 July 2018
Christopher Bunt | 20 July 2018
